For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
New Zealand firm aims to supply pig kidneys for human transplant
+News
In print
Upfront
New Zealand firm aims to supply pig kidneys for human transplant
Wednesday 17 July 2024, 02:45 PM

Research company NZeno is working on the concept of transplanting organs from genetically edited Auckland Island pigs into humans [Image: Wikimedia Commons]
Viewers of Shortland Street were introduced to xenotransplantation at the fictional hospital earlier this month.
Long-time readers of New Zealand Doctor Rata Aotearoa may be familiar with xenotransplantation research being carried out by the late diabetes researcher Sir Robert Elliot. Martin Johnston updates that story
We hope maybe we would have some data to get into human trials
New Zealand-based researchers who encapsulated pig cells to treat type 1 diabetics
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.